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Abstract We investigated the physiology and function of P2Y
receptors expressed in human dendritic cells (DCs) differentiated
in vitro from CD14+ cells (DC-14). These were obtained after a
10 day stimulation period in GM-CSF, IL-4 and monocyte
conditioned medium. DC-14 were found to express high amounts
of MHC class II, B7, CD40 as well as CD83. The functional
analysis, using single cell Ca2+ imaging, demonstrated the
expression of at least three subtypes of P2Y receptors. We
further found using patch-clamp measurements that ATP evoked
a pertussis toxin insensitive non-selective cation current with a
peak current amplitude of 3276 þ 43 pA (holding potential 380
mV, n = 23). This current was not Ca2+-activated, since it was
still observed under conditions of high intracellular Ca2+
buffering and could be blocked by Gd3+ (0.5 mM). In addition,
intracellular application of GTP-Q-S (0.3 mM) also activated the
current. Interestingly, DC-14 redirected the orientation of their
dendrites as well as cell shape towards a pipette containing ATP
as observed with time lapse microscopy. These data suggest that
in human DCs, ATP acts via P2Y receptors and induces
chemokine effects.
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1. Introduction
Dendritic cells (DCs) are known as the most competent and
e⁄cient cells to induce primary and secondary immune reac-
tions. The distribution pattern of DCs ranges from primary
lymphatic organs in which the phenotype is known as FDC to
skin derived DCs known as Langerhans cells [1]. It is common
knowledge that DCs exhibit enormous capacities to present
tumorigenic antigenic peptides in both class I [2,3] and class II
restricted immune responses and so far, detailed insight has
been gained mainly into aspects of antigen processing and
presentation [4^6]. Relatively little is known about the chemo-
tactic events and the involved signaling mechanisms leading to
DC recruitment. Whereas the uptake of soluble antigens or
immune complexes can be explained by FC-mediated path-
ways [7^9], the recognition of antigens derived from necrotic
or apoptotic cells is still under discussion. Since ATP is re-
leased from damaged cells and since purinergic receptors
[10,11] are known to be expressed on a variety of immuno-
logical cells [12^17], we tested whether ATP may activate DC-
14. In particular, the expression and function of purinergic
receptors was studied.
We demonstrate that DC-14 express functionally coupled
P2Y receptors. Extracellular application of ATP resulted in
a transient increase of the free cytosolic Ca2 concentration
[Ca2]i and concomitant activation of a non-selective cation
current. Moreover, a possible role of these purinergic recep-
tors in ATP-mediated chemotaxis is suggested.
2. Materials and methods
2.1. DC generation
To isolate monocytes from peripheral blood, CD14 expressing cells
were positively enriched using CD14 coupled paramagnetic microbe-
ads (Miltenyi Biotech, Bergisch Gladbach, Germany) and the Mini-
MACS separation system (Miltenyi Biotech) according to the recom-
mended protocol. Cells were cultured in RPMI 1640, supplemented
with glutamax I (Gibco, BRL, Gaithersburg, MD, USA), 5% FCS
(Gibco), 10 Wg/ml cipro£oxacin (Ciprobay, Bayer, Leverkusen, Ger-
many) containing GM-CSF (Sigma, Deisenhofen, Germany) (800 U/
ml) and IL-4 (Essex Pharma, Munich, Germany) (1000 U/ml) in six
well plates (Nunc, Wiesbaden, Germany) at a concentration of 106/ml
for 10 days.
2.2. Cell surface marker analysis
Analysis of cell surface markers was performed by £ow cytometry
(FACSort, Becton Dickinson, Heidelberg, Germany). DC-14 (2U105)
were stained for 15 min at 4‡C in PBS, 0.1% BSA, 0.01% NaN3 with
20 Wl of PE, FITC or PerCP labeled monoclonal antibodies: CD1a,
CD4, CD5, CD11a, CD11b, CD14, CD18, CD23, CD33, CD45RA,
CD45RO, CD54, anti-HLA-DR (Becton Dickinson), CD30, CD30L,
CD40, CD40L (Immunex Inc., Seattle, WA, USA), CD80, CD86
(Ancell, Bayport, MN, USA). After the staining procedure samples
were washed twice in 1 ml PBS. Speci¢c £uorescence intensity was
de¢ned by the ratio of the £uorescence intensity of the surface marker
to the £uorescence intensity of the isotype control.
2.3. Single cell Ca2 + imaging experiments
DC-14 were kept in RPMI medium (Gibco) loaded with 0.5 WM
fura-2-AM (Molecular Probes, Leiden, The Netherlands) in the incu-
bator for 10 min, washed once with medium, centrifuged at 1000 rpm
for 5 min and resuspended in RPMI. Then the cells were put into a
temperature controlled recording chamber and superfused with ex-
tracellular solution for 10 min prior to starting the experiment. Mono-
chromic excitation light (340^380 nm) was produced by a computer
controlled monochromator (TIL Photonics, Munich, Germany) and
coupled to the epi£uorescence attachment of an inverted microscope
(Axiovert 135TV, Zeiss, Germany) through a small quartz light guide.
The excitation light was directed to the £uorescent objective (40U,
Zeiss) via a dichroic mirror (TIL Photonics). The emitted £uorescence
from the fura-2 loaded cells was imaged through a 470 nm interfer-
ence ¢lter using an intensi¢ed charge coupled device camera (Thetha,
Munich, Germany) connected to the TV port of the inverted micro-
scope. Fluorescence images (50 ms exposure time) were acquired at
0.33 Hz using the Fucal £uorescence software package (TIL Pho-
tonics). Images were displayed on-line and stored on hard disk. The
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analysis of the data was done o¡-line using the Fucal software pack-
age. Within cursor de¢ned areas of interest paired 340/380 images
were background subtracted and the ratio calculated. The absolute
ratio values in the cursor de¢ned areas were exported into Sigmaplot
(Jandel Scienti¢c, Germany) and the [Ca2]i concentration estimated,
using the equation of Grynkiewicz et al. [18]. In situ calibration fac-
tors were determined in vitro on groups of cells and averaged, Rmax
(340/380 ratio) obtained in presence of 5 mM ionomycin and 10 mM
Ca2, Rmin (340/380 ratio) in presence of 5 mM ionomycin and excess
EGTA, and F380min were determined. The values used for Rmax, Rmin
and F380min were 2.6, 0.35 and 3.7, and a dissociation constant (Kd)
of 224 was used.
2.4. Patch-clamp recordings
Standard whole-cell [19] and perforated patch-clamp techniques [20]
were used for the recording of ion currents. Electrodes were pulled
with a DMZ universal puller (DMZ, Munich, Germany) from 1.5 mm
borosilicate glass capillaries (Clark Electromedical Instruments, Read-
ing, UK), and ¢re-polished to resistances of 4^5 M6. Ionic currents
were recorded using an EPC-9 patch-clamp ampli¢er (HEKA, Ger-
many). Data were acquired with the Pulse/Pulse-Fit software package
(HEKA). Liquid junction potentials, series resistance and cell capaci-
tance were compensated using the internal circuit of the ampli¢er. For
perforated patch recordings, freshly made stock solution of nystatin
(50 mg/ml in dimethyl sulfoxide) was diluted to a ¢nal concentration
of 150 Wg/ml in pipette solution. In order to allow appropriate voltage
clamp control, measurements were only started after the access resist-
ance (Rs) dropped below 30 M6 (about 5^10 min after formation of
G6-seal). Good voltage clamp was obtained since Na currents ex-
pressed in some of the DCs could be appropriately recorded.
For measurements of the instantaneous current-voltage relationship
of ATP-induced currents, 150 ms ramp depolarization were applied
every 1.5 s from 3100 mV to 50 mV. Control currents were obtained
immediately before ATP application and were subtracted from the
ATP-induced current, as indicated. Continuous recordings were
stored on videocassette recorder tape following pulse code modulation
(VR-100A, Instrutech, Great Neck, NY, USA). Combined Ca2
imaging/patch-clamp experiments were synchronized by using a TTL
pulse generated by the EPC-9 to initiate the acquisition of the images.
For analysis, data were downloaded from the videotape via pulse-
code modulator into a software program (Axon Instruments, USA)
at a sampling rate of 250 Hz and ¢ltered at 100 Hz. Files in ASCII
format were imported into Sigmaplot. Continuous observation of
dendritic cells was performed using a sensitive video-camera (TIL
Photonics). After the experiment videoimages were digitized and fur-
ther analyzed using Adobe Photoshop software.
For electrophysiological experiments agonists were applied using a
pu¡er pipette connected to a pressure ejection device (Picospritzer,
General Valve, USA). The pipette was placed in close vicinity to
the cell using a micromanipulator. For the experiments using two
substances, a double barrel tubing connected to two separate perfu-
sion pumps (Braun, Melsungen, Germany) providing steady £ow rates
were used. For Ca2 imaging experiments reagents were applied di-
rectly to the bath or by using the double metal tubing. The total
amount of ATP added is indicated in this paper. ATP was dissolved
in the appropriate solution prior to use and pH corrected. The addi-
tion of 0.25 mM ATP to the normal extracellular solution yielded a
free ATP concentration of 14.6 WM, whereas in the Ca2 free extra-
cellular solution free ATP was 34.5 WM as calculated with the Chelator
software program (University of Nijmegen, The Netherlands).
The solutions used were of the following composition (in mM):
normal extracellular solution: 140 NaCl, 4.5 KCl, 1 MgCl2, 2 CaCl2,
5 HEPES, pH = 7.2 (NaOH). Extracellular low Na solution: 30
NaCl, 110 NMDG, 4.5 KCl, 1 MgCl2, 2 CaCl2, 5 HEPES, pH = 7.2
(NaOH). Extracellular low Cl3 solution: 50 CsCl, 90 Cs-acetate, 4.5
KCl, 1 MgCl2, 2 CaCl2, 5 HEPES, pH = 7.2 (CsOH). Extracellular
Ca2-free solution: 140 NaCl, 4.5 KCl, 1 MgCl2, 5 HEPES, pH = 7.2
with NaOH. Normal intracellular solution (in mM): 134 CsCl,
2 MgCl2, 1 EGTA, 10 HEPES, pH = 7.2 (CsOH). Intracellular low
Cl3 solution (in mM): 26 KCl, 114 K-aspartate, 2 MgCl2, 1 EGETA,
10 HEPES, pH = 7.2 (KOH). All experiments were performed at room
temperature (22^26‡C). Gadolinium chloride (Sigma), adenosine 5P-
triphosphate (ATP) (Sigma), 2-methylthioadenosine triphosphate tet-
rasodium (2-MeSATP, RBI, USA), guanosine 5P-triphosphate (GTP,
Sigma), were dissolved in the normal extracellular solution. Guano-
sine 5P-o-(3-thiotriphosphate) (GTP-Q-S, Sigma) was dissolved in nor-
mal intracellular solution. Fura-2-AM (Molecular Probes), fura-2
pentapotassium salt (fura-acid, Molecular Probes), ionomycin (Mo-
lecular Probes) and Tg (Molecular Probes) were dissolved as stock
solution in dimethyl sulfoxide (DMSO) and diluted to the ¢nal
concentration prior to application (¢nal concentration of DMSO
6 0.1%). Pertussis toxin (PTX) was obtained from Sigma. DC-14
were incubated in PTX (1 Wg/ml) for 12 h. Averaged data are ex-
pressed as mean þ S.E.M.
3. Results and discussion
3.1. Characterization of DC-14
Using the magnetic cell separation system (MACS) for pos-
itive enrichment of CD14 expressing cells, preparations of
s 95% purity were used. To obtain in vitro generated DC-
14, enriched CD14 PBMC were cultured with GM-CSF/IL-4
and TNF-K (added during the last 2 days of the di¡erentia-
tion period) for 10 days. Expression of CD1a, CD40, CD80,
CD86 and HLA-DR was strongly upregulated, as would be
expected for DC-14. These show a positive staining for
CD11b, CD18, CD33 and CD45RO. Two color £ow cytomet-
ric analysis demonstrated a homogeneous cell population in
the DC-14 with respect to cell marker distribution. After 10
days of culture in the presence of GM-CSF, IL-4 and TNFK,
the DC-14 displayed a homogeneous population with DC-like
features such as characteristic processes and accumulated mi-
tochondria (data not shown). In order to characterize further
the DC population the cytokine pro¢le was analyzed by RT-
PCR and ELISA at day 10 of the in vitro di¡erentiation. It
could be demonstrated that the DC-14 express a speci¢c cy-
tokine pattern with the presence of IL-1a, IL-1b, TNF-K,
GM-CSF and the absence of IL-2, IL-4, IFN-Q at the
mRNA and protein level (data not shown). Furthermore,
highly puri¢ed CD4 positive autologous T cells were stimu-
lated with the di¡erentiated DC-14 to analyze their capacity
to induce a primary and secondary antigen speci¢c T-cell re-
sponse. Within the experiments only DC-14 with a prominent
antigen-presentation capacity were used.
3.2. DC-14 express functional P2Y receptors
Human CD14 derived cells were investigated at di¡erent
time points (day 0^10) during di¡erentiation using single cell
Ca2 imaging- and/or patch-clamp techniques. At all di¡er-
entiation stages relatively linear current voltage (I/V) relation-
ships were observed using ramp depolarization. In contrast to
the ¢ndings in murine DCs [21] in the human DC-14 no in-
ward recti¢er K currents and outward recti¢er K currents
of only small amplitude were detected (data not shown). Since
purinergic receptors have been detected on a variety of immu-
nological cell types we tested the e¡ect of extracellular appli-
cation of ATP on DC-14. Using single cell Ca2 imaging,
ATP was found to evoke a fast, transient increase of [Ca2]i
in almost all DC-14 tested (Fig. 1A, n = 131). A consistent
response to ATP similar to terminally di¡erentiated DC-14
was observed starting from day 5 of di¡erentiation. The aver-
age resting [Ca2]i in DC-14 was 53 þ 2 nM and application of
ATP (0.25 WM, free = 14.6 WM) resulted in peak [Ca2]i of
1001 þ 119 nM (n = 6). The threshold concentration of ATP
for evoking a [Ca2]i transient was 0.5 WM, at this concen-
tration, however, the peak [Ca2]i response was small
(473 þ 45 nM, n = 5). In order to distinguish between P2X
and P2Y receptors, we tested whether ATP induced Ca2
release from intracellular stores. As expected for P2Y recep-
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tors [10], ATP evoked a transient [Ca2]i increase in nomi-
nally Ca2 free extracellular solution (Fig. 1B, n = 150). The
ATP induced depletion of intracellular Ca2 stores was fur-
ther proven by Tg, a Ca2-ATPase inhibitor [22]. After appli-
cation of ATP, Tg did not evoke an additional increase of
[Ca2]i (Fig. 1B) in line with ATP emptying the intracellular
stores. Tg evoked a sustained rise in [Ca2]i upon the read-
dition of extracellular Ca2, which was completely blocked by
1 WM Gd3, indicating the activation of the store depletion
activated current (ICRAC, Fig. 1B) [23]. In contrast, extracel-
lular ATP caused only a transient [Ca2]i increase (Fig. 1A).
In order to characterize the functionally expressed P2Y recep-
tor subtypes [24] the P2Y1 selective agonist 2-MeSATP [25^
27] (2^7) was ¢rst applied; then the P2Y2 [28,29] and P2Y4
[30,31] agonist UTP was added. As depicted in Fig. 1C,
2-MeSATP as well as UTP evoked similar to ATP a transient
[Ca2]i increase in DC-14. Moreover, subsequent application
of ATP in the presence of 2-MeSATP and UTP caused an
additional transient [Ca2]i response in most cells suggesting
the functional expression of 2-MeSATP and UTP insensitive
P2Y receptors (Fig. 1C). Accordingly, the application of ATP
prevented the subsequent 2-MeSATP- and UTP-induced
[Ca2]i elevation (data not shown). A summary of three rep-
resentative experiments where the di¡erent agonists were ap-
plied in the order 2-MeSATP-UTP-ATP demonstrated that
most of the cells tested express at least three subtypes of
P2Y receptors (Fig. 1D).
3.3. ATP activates a non-selective cation current in DC-14
Next, we wondered whether P2Y receptor activation was
associated with changes in membrane conductance. Combined
single cell Ca2 imaging and perforated patch-clamp record-
ing evidenced that ATP evoked both, the increase of [Ca2]i
(Fig. 2Aa) and the activation of an inward current (Fig. 2Ab,
HP =380 mV, n = 4). This current was of a slowly activating
and inactivating nature. As depicted in Fig. 2Aa/b the increase
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Fig. 1. ATP activates P2Y receptors in CD14 derived human DCs. A: Application of 0.25 mM ATP (free ATP = 14.6 WM) resulted in almost
all DC-14 in a transient increase of [Ca2]i. The magnitude of the [Ca2]i rise varied between cells, however, in all responding cells a fast return
to control [Ca2]i levels was noticed. B: ATP evoked in nominally free Ca2 solution (free ATP = 34.5 WM) the depletion of intracellular Ca2
stores. This evidenced that the ATP response was mediated through activation of P2Y receptors. The subsequent application of Tg did not re-
sult in an additional release of Ca2 from intracellular stores, excluding that the ATP action was restricted to a subclass of intracellular Ca2
stores. Reperfusion with 2 mM Ca2 containing extracellular solution resulted in a sustained increase of [Ca2]i, which could be completely
blocked by Gd3 (1 WM). C: DC-14 expressed several subtypes of P2Y receptors, since the majority of cells responded with transient [Ca2]i in-
creases to the sequential application of 2MeSATP, UTP and ATP. D: Statistics from three representative experiments where P2Y receptor ago-
nists were applied in the same order as in C. It is shown that most of the DC-14 cells coexpressed at least three di¡erent P2Y receptor sub-
types. Furthermore, it can be seen that there is variability among the human DC-14 in regard to P2Y receptor expression.
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in [Ca2]i preceded the activation of the current and the aver-
age delay between the onset of the rise in [Ca2]i and the
activation of the current amounted to 2.9 þ 1.9 s (n = 4). The
instantaneous I/V relationship was linear and yielded a rever-
sal potential close to 0 mV (Fig. 2Ac, average value of
311.8 þ 0.5 mV for n = 4). ATP evoked this slowly activating
and inactivating inward current at a holding potential (HP) of
380 mV in almost all DC-14 tested with an average amplitude
of 3276 þ 43 pA (n = 23). The current could be activated re-
petitively (n = 2), however, the amplitude decreased indicating
receptor desensitization (Fig. 2B). To identify the nature of
the current, ion replacement experiments were performed.
Substitution of extracellular Na by NMDG led in the in-
stantaneous I/V relationships to a signi¢cant left shift
(349 þ 5 mV, n = 2) of the reversal potential (Fig. 2Ca/b). In
contrast, replacement of extracellular or intracellular Cl3 by
acetate or aspartate did not alter the reversal potential with
values of 34.5 þ 2 mV (n = 2) and of 38.5 þ 2.5 mV (n = 2,
Fig. 2Cc), respectively. These results demonstrate that P2Y
receptor activation leads to the activation of a non-selective
cation current. Since the increase in [Ca2]i was observed
before the onset of the inward current (Fig. 2Aa/b), we inves-
tigated whether the current was Ca2 activated. Therefore,
DC-14 were dialyzed with 10 mM EGTA and 100 WM fura-
2 to prevent ATP-induced [Ca2]i increase. As can be seen in
Fig. 3Aa/b, ATP still activated the inward current 5 min after
the establishment of the classic whole cell con¢guration (Fig.
3Ab), however, no concomitant elevation of [Ca2]i occurred
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Fig. 2. ATP-mediated P2Y receptor activation evokes a non-selective cation current in human DC-14. Aa^Ac: Application of ATP (0.25 mM)
through a pu¡er pipette led in a fura-2-AM loaded human DC to a transient [Ca2]i rise (Aa) and the activation of a slowly activating and in-
activating inward current in the continuous presence of the agonist (perforated patch clamp technique, HP =380 mV, Ab). Intermittently volt-
age ramps were applied (3100^50 mV, 150 ms, Ab). Subtraction of voltage ramps (marked with a star) in the presence and absence of ATP
(Ab) yielded a linear I/V relationship for the ATP induced current with a reversal potential close to 0 mV (Ac). The parallel monitoring of
Ca2 and membrane currents also evidenced that the [Ca2]i rise initiated prior to the activation of the inward current (see also double arrow
marking the beginning of the [Ca2]i increase, Ab). B: 1 s lasting ATP applications through a pu¡er pipette evoked in a voltage clamped DC
(perforated patch-clamp con¢guration, HP =380 mV) the slowly activating and inactivating inward current. Repetitive applications of ATP re-
sulted in a decrease of the current amplitude indicating receptor desensitization. Ca^Cc: Isomolar replacement of extracellular Na (110 mM)
by NMDG caused a pronounced shift of the reversal potential to negative potentials (HP =380 mV, subtracted voltage ramps are indicated
with a star, Cb). Conversely, replacement of intracellular Cl3 by aspartate did not result in a change of the reversal potential (Cc), proving
that the ATP-evoked current was of a non-selective nature.
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(Fig. 3Aa, n = 8). This was further con¢rmed, by experiments
where the application of Tg did not result in current activa-
tion, whereas subsequently applied ATP evoked the character-
istic inward current (n = 4, data not shown). We further inves-
tigated possible inhibitors of the ATP evoked non-selective
cation current. While the P2X/P2Y receptor blocker suramin
(100 WM) did not prevent current activation (n = 2, data not
shown), Gd3 (0.5 mM) completely blocked the ATP response
(Fig. 3B, n = 3). An involvement of G proteins of the Gi/Go
subfamily in the activation of the current was also excluded
since preincubation in PTX did not prevent current activation
by ATP (Fig. 3Ca, n = 4). Because the inward current was not
activated by Ca2, we tested whether G-protein activation was
su⁄cient to evoke the current. Indeed, infusion of GTP-Q-S
(300 WM), a permanent activator of all G-proteins resulted in
the activation of a sustained inward current; subsequent ap-
plication of ATP was without e¡ect (Fig. 3Cb, n = 4), suggest-
ing that the ATP- and GTP-Q-S activated currents were iden-
tical. The current density of the ATP evoked inward current
(HP =380 mV) was almost identical under control conditions
and upon incubation in PTX (Fig. 3Cc). Conversely, the
GTP-Q-S induced current density was signi¢cantly higher
(Fig. 3Cc), probably due to the activation of all available
G-proteins.
Because P2Y receptor activation shared identical signal
transduction cascades as described for chemokine receptors
[32], we analyzed whether any changes in the orientation of
dendrites and cell shape could be observed in DC-14 upon site
directed application of ATP. For this purpose a glass pipette
containing high ATP concentration (1 mM) was placed in the
recording chamber. Typically, over time a reorientation of
dendrites and of cell shape towards the ATP containing pi-
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Fig. 3. Regulation of ATP evoked inward currents. Aa, Ab: Representative experiment where intracellular stores were Ca2 depleted by dialyz-
ing the cell via the patch pipette in the classic whole cell con¢guration with high concentrations of fura-acid (100 WM) and EGTA (10 mM) for
5 min. The subsequent application of ATP resulted in activation of the typical inward current (Ab), whereas no transient increase of the 340/
380 ratio (Aa) was noted. This indicated that the ATP evoked current was not Ca2 activated. B: The ATP evoked non selective cation current
was inhibited by Gd3 (0.5 mM, HP =380 mV). Ca-Cc: ATP activated the inward current also in PTX preincubated DC-14, excluding the in-
volvement of G proteins of the Gs/Gi type (Ca). Similarly, inclusion of GTP-Q-S (0.3 mM) in the patch pipette resulted in the activation of a
non inactivating inward current (HP =380 mV, Cb). Application of ATP after full establishment of the GTP-Q-S evoked inward current was
without e¡ect (Cb). The statistical signi¢cant di¡erence of current densities evoked by ATP, in the presence of PTX and by GTP-Q-S is shown
(Cc, unpaired Student’s t-test 6 0.01).
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pette was observed (as shown in the time lapse pictures in Fig.
4). Control experiments using normal extracellular solution
instead of ATP did not result in similar changes (data not
shown). When the pipette was repositioned, de novo reorien-
tation of dendrites and of cell shape occurred (Fig. 4C), ex-
cluding that this could be related to a toxic e¡ect of ATP.
Taken together we present evidence that human DC-14 ex-
press at least three subtypes of functionally coupled P2Y re-
ceptors but none of the P2X family. This is in clear contrast
to human macrophages where the functional expression of
P2X receptors was described [15,33]. Interestingly, P2Y recep-
tor activation leads to a transient rise of [Ca2]i and a con-
comitant activation of a non-selective cation current.
Although in rat macrophages ATP evoked a non-selective
cation current [34,35], the receptors involved were of the
P2X7 subtype and the biophysical characteristics of the cur-
rents di¡ered from our ¢ndings in CD14-derived DCs primar-
ily by the slow activation kinetics and the inactivation in
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Fig. 4. Human DC-14 reorientate dendrites and cell shape towards an ATP containing pipette. The numbers on the left side indicate time
points in min when pictures of the continuous video-sequence were taken for digitization. In order to show the changes occurring over time the
original pictures displayed on the left side (I) are also displayed in the relief mode (II): Representative images of continuous video-microscopic
monitoring of orientation of dendrites as well as of cell shape of DC-14 cells in vicinity of a glass pipette ¢lled with normal extracellular solu-
tion containing 1 mM ATP. 40 min after positioning the pipette (t = 40) the orientation of the dendrites as well as of cell shape (A, B and C)
clearly changed as compared to the control picture acquired immediately prior to proper placement of the pipette (t = 0). Further change of the
pipette position (shortly after acquisition of t = 40) resulted again in reorientation of dendrites as well as of cell shape towards the ATP con-
taining pipette (t = 60), excluding that the changes observed were a result of ATP toxicity. Calibration bar equals 5 Wm.
Q.H. Liu et al./FEBS Letters 445 (1999) 402^408 407
presence of ATP. Because of the similarity between the P2Y
and chemokine receptor coupling the e¡ect of ATP on DCs
was tested. We demonstrate, to our knowledge for the ¢rst
time, that local ATP application leads to reorientation of
dendrites and changes of cell shape. Because of the reorienta-
tion of DC-14 after the position change of the application
pipette and the lack of P2X7 expression on human DC-14,
ATP induced cell lysis can be excluded [36]. Our observations
imply a novel role for P2Y receptors as possible chemokine
receptors. Since within in£ammatory sites infected or dying
cells are likely to release ATP, this mechanism may serve as
an important stimulus for redirecting DCs to entry sites of
pathogens.
Future studies should be directed to clarify this in more
detail using classic cell migration assays as well as various
pharmacological agents (ATP, Gd3, etc.). Moreover, the
functional role of the transient [Ca2]i increase and the non-
selective cation current has to be further investigated.
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